T & B Cell Flow Crossmatch is a highly sensitive laboratory test performed before organ transplantation, especially kidney transplantation, to detect harmful antibodies in the recipient’s blood against donor lymphocytes (T-cells and B-cells). This test helps assess compatibility between donor and recipient and reduces the risk of graft rejection.
Flow cytometry technology provides accurate detection of donor-specific antibodies (DSAs), making it more sensitive than conventional crossmatch methods.
Specimen
Peripheral Blood
Method
Flow Cytometry
Purpose of the Test
Evaluate donor-recipient compatibility before transplantation
Detect preformed anti-HLA antibodies
Assess risk of acute or hyperacute rejection
Support transplant planning and immunological assessment
Components
T-Cell Crossmatch
Detects antibodies against HLA Class I antigens
Positive results may indicate higher risk of acute rejection
B-Cell Crossmatch
Detects antibodies against HLA Class I and Class II antigens
More sensitive for identifying donor-specific antibodies
When is the Test Recommended?
Before kidney transplantation
Prior to liver, heart, lung, or bone marrow transplant
In sensitized transplant recipients
History of previous transplant rejection
Patients with multiple blood transfusions or pregnancies
Clinical Significance
Negative Crossmatch
Indicates no significant donor-specific antibodies detected
Suggests lower risk of antibody-mediated rejection
Usually considered favorable for transplantation
Positive Crossmatch
Indicates presence of antibodies against donor cells
Increased risk of transplant rejection
May require desensitization therapy or alternative donor selection
Advantages of Flow Crossmatch
Highly sensitive and specific
Early detection of low-level antibodies
Better transplant outcome prediction
Improved graft survival assessment
Turnaround Time
Usually 24–72 hours
Preparation
No special preparation required
Inform the clinician about recent transfusions, transplants, or immunotherapy